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CHAPTER I 
INTRODUCTION 
Extensive investigation has centered around the function of high 
density lipoprotein cholesterol (HDL-C). This research is a product of 
evidence by the Framingham study and others of an inverse relationship 
between plasma (or serum) HDL-C levels and incidence of coronary heart 
disease (CHD) (1-6). Several theories have been put forth to charac-
terize the role of HDL-C in CHD. Glomset suggests that HDL-C plays a 
major role in the removal of cholesterol from the peripheral tissues to 
the liver, thus decreasing deposition (7). Carew and his associates 
found that cells incubated with equal or higher HDL-C concentrations 
show no accumulation of cholesterol deposition. It is suggested that 
HDL-C acts in removal of cholesteryl ester and phospholipid decompo-
sition of very low density lipoprotein from the plasma (8). The precise 
function of HDL-C in its association with CHD is still unclear at 
present. 
Collaborating research related to CHD has been supportive of a 
decreased incidence of CHD associated with regular physical activity (9-
13). There may be a possible connection between a decreased incidence 
of CHD with higher HDL-C levels and regular physical activity. It has 
been suggested that chronic physical activity increases concentrations 
of HDL-C in the blood. There is evidence to support modification of 
risk factors by physical acitivty (14-17); however, increased HDL-C 
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concentrations associated with physical activity is contradictory. 
Several studies have demonstrated higher HDL-C levels in trained 
than in non-trained individuals (18-29). Increased levels of HDL-C have 
been found in cross country skiers, male and female middle-aged runners, 
elite long distance runners and marathoners, anq male and female tennis 
players. Contradictory evidence by other. investigators has not been 
supportive of the physical activity-HDL-C relationship (30-35). The 
research design of these studies has contributed to the contradictory 
evidence of the exercise-HDL-C association. Cross sectional design, 
insufficient dietary and physical activity data, small numbers of sub-
jects, and the small number of randomized training studies has contri-
buted to this variability. Therefore, further investigation into the 
relationship of exercise to HDL-C is warranted. 
Statement of the Problem 
The purpose of this investigation was to characterize the effect of 
12 weeks of exercise training on plasma high density lipoprotein 
cholesterol in men aged 30-50. 
Hypothesis 
Twelve (12) weeks of exercise training will have no effect on 
plasma high density lipoprotein cholesterol. 
Significance of the Study 
This study offered a randomized training protocol with experimental 
and control groups utilizing large numbers of subjects (> 30 subjects 
per group). This design provided further experimental data to 
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characterize the effect of exercise on HDL-C. 
Assumptions 
1. It was assumed that all subjects answered truthfully the ques-
tionnaires on diet, alcobol consumption, smoking history, and 
physical activity history. 
2. It was assumed that all subjects adhered .to the instructions to 
maintain their dietary and alcohol consumption habits prior to 
the study, during the course of the study. 
Limitations 
1. The subjects involved in this study were volunteers and not a 
random sample from a normal population. 
2. The methods used to assess dietary and alcohol consumption 
habits lacked quantitative analysis. 
3. The training period for this study was only 12 weeks. 
4. The subjects were under no obligation and retained the right to 
withdraw from the study at any time. 
Delimitations 
1. Seventy-two men from the Tulsa area, aged 30-50, were examined 
in this investigation. 
2. All subjects were "inactive", exercising less than three times 
per week six months prior to the study. 
3. Only subjects free of known CHD or symptoms of CHD were 
selected for this study. 
4. Only HDL-C was examined in this study, not the apolipoproteins 
of HDL-C. 
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Definition of Terms 
Beckman Metabolic Measurement Cart: A cardioplumonary instrument 
utilized in the measurement of oxygen consumption (VOz) (36). 
Control Group: The group that did not receive the treatment effect 
of 12 weeks of organized exercise. 
Experimental Group: The group that underwent the treatment effect 
of 12 weeks of organized exercise. 
CHAPTER II 
REVIEW OF LITERATURE 
Interest in HDL-C has sparked a large number of studies examining 
the effect of physical activity on HDL-C. ·Because of the large number 
of studies in this area, the author did not attempt to present a compre-
hensive review of literature. Rather, selected studies which are repre-
sentative of the research in th~ area are presented. The review of 
literature focused on three specific areas in regard to the exercise-
HDL-C: (1) cross sectional research on exercise-HDL-C; (2) exercise 
training protocols on HDL-C; and (3) related effects of diet, alcohol 
consumption, and cigarette smoking. 
Cross Sectional Research 
Research by Wood (21, 22) evaluated HDL-C concentrations in male 
and female runners. The study involved comparing HDL-C levels in 41 
male and 43 female runners with a random subset of 147 male and 93 
female control subjects. The control subjects were derived from 747. 
males and 923 females who were generally sedentary and inactive. A few 
active individuals were included in the control group. The runners 
exercised a minimum of 15 miles per week for the previous year. Follow-
ing a 12-16 hour fast, blood samples were taken and lipid concentrations 
compared. Significantly higher HDL-C levels were found in the runners 
than in the control subjects, both males and females. 
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Adner and others (25) studied the effects of distance running 
on HDL-C levels in 50 distance runners. These runners were matched for 
age and sex with a control group of 43 subjects. Each group had one 
female subject, all other subjects were male. Distance runners were 
defined as individuals who ran more than 500 miles per year. In con-
trast, control subjects were defined as-individuals who did not run more 
than 500 miles per year. Upon evaluation of HDL-C concentrations, the 
distance runners had significantly higher HDL-C compared with the 
matched controls. 
Middle-aged marathon runners (n = 59), joggers (n = 85), and inac-
tive men ( n= 74) were studied by Hartung and his associates (19). The 
marathon runners and joggers averaged 40 miles per week and 11 miles per 
week running, respectively. Blood samples were drawn after a 12-16 hour 
fast, and mean HDL-C levels for the groups were as follows: 1) marathon 
runners - 65 mg per deciliter; 2) joggers - 58 mg per deciliter; and 3) 
inactive men - 43 mg per deciliter. Hartung found significantly higher 
HDL-C concentrations in joggers and marathon runners than in inactive 
men. Marathon runners also demonstrated significantly higher HDL-C 
levels than joggers. 
Martin and others (24) did a similar study on young male (26-30 
years of age) elite runners (n = 20), good runners (n = 8), and age 
matched controls (n = 72). The categories of elite runners, good run-
ners, and control subjects were determined by the activity level indi-
cated by the subject on a physical activity questionnaire. Analysis of 
HDL-C demonstrated significantly higher values in all groups of runners 
versus their control counterparts~ 
Contrasting data has also appeared which has not been supportive 
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of the exercise-HDL-C association. Mjos and Thelle (32) compared a 
highly active group of 139 females and 110 males with a sedentary con-
trol group of 112 females and 84 males. The highly active group was 
determined by those individuals who exercised more than four hours per 
week, all other subjects comprised the sedentary control group. When 
HDL-C levels were compared between the groups, no significant difference 
was found. 
Ho and Chan (30) studied the effect of exercise on HDL-C. Their 
study of young Chinese adults compared a group of 19 who engaged in hard 
frequent exercise to a group of 22 who did little or no exercise. The 
criteria for determining the exercise group was physical activity in 
excess of three hours per week. After a 12-hour fast, blood samples 
were drawn and lipids assayed. Statistical analysis did not demonstrate 
-~significantly higher HDL-C levels in the exercise group. 
Schwane and Cundiff studied HDL-C in relationship to physical 
activity and cardiorespiratory (CR) fitness. One hundred and fifty col-
lege aged adults, 66 males and 84 females, volunteered to participate in 
the study. Physical ativity and HDL-C showed no significant correlation 
in males or females. However, CR fitness and HDL-C did show a signifi-
cant positive correlation tn both males and females. 
From the cross sectional research it is evident that conflicting 
results have been found in regard to the exercise-HDL-C question. The 
cross sectional design has been useful in identifying extremes in HDL-C 
levels (distance runners vs. sedentary individuals), however, it can not 
demonstrate a cause-effect relationship. As a result, it is necessary 
to further examine the exercise-HDL-C question with more powerful 
research designs which can demonstrate a cause-effect relationship. 
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Exercise Training Protocols 
A 16-week training study involving 100 asymptomatic middle-aged 
men was undertaken by Huttunen (29). All subjects were assessed for 
fitness and blood lipids before the training session. Subjects were 
randomized into exercise and control groups. Controls were instructed 
to maintain current activity level, while the exercise group met three 
or four times per week for 30 minutes of exercise. · The primary form of 
exercise was walking and jogging. Following the 16-week training 
period, all subjects were reassessed on fitness and blood lipids. The 
exercisers demonstrated significantly higher HD~-C levels than did the 
sedentary control group. Also, an increase fitness level was demon-
. 
strated by increased V02 in the exercise group. 
Leon and his associates (28) studied the effects of 16 weeks of 
vigorous treadmill walking on blood lipids in six sedentary obese men. 
Subjects exercised for 90 minutes, five days per week at 3.2 miles per 
hour up a 10 percent grade. Following the training period the group 
demonstrated a 15.6 percent increase in HDL-C over the pretraining 
levels. 
Farrell and Barboriak (27) studied the effects of eight weeks of 
endurance training on lipoproteins concentrations. Sixteen subjects 
were studied, seven males and nine females. The subjects exercised at 
70 percent VOz maximum, 30 minutes per day, and three or four days per 
week. Evaluation of HDL-C concentrations showed significantly higher 
values at post-training. 
Other training protocols have not been supportive of the exercise-
HDL-C association. Moll (31) studied the effect of six weeks of vigor-
ous exercise on 14 non-obese women ages 22-26. The subjects exercised 
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30-45 minutes by jogging five days per week. The subjects were 
assessed before and after the training program on aerobic performance, 
total cholesterol, and HDL-C. The subjects demonstrated a significant 
increase in aerobic performance. Total cholesterol fell significantly, 
but HDL-C was not significantly different, however, it was slightly 
lower. 
Wood and others (35) looked at the effects of one year of exercise 
on plasma lipoproteins in 81 males ages 30-55. The subjects were ran-
domly assigned to either the exerci.se group (n = 48) or the control 
group (n = 33). Following one year of training the average miles run 
per week by the exercise group ·ranged from 0-21 (median 8.6). No sig-
nificant difference was observed in HDL-C levels between the exercise 
group and the control group. A significant positive correlation was 
found between HDL-C and miles per week run. 
Research by Allison studied the effect of eight weeks of aerobic 
exercise on 49 women and 39 men of college age. Subjects were random-
ized into three groups: 1) control-group - no exercise; 2) exercise 
group - three times per week for 30 minutes; and 3) exercise group -
three times per week for 45 minutes. All subjects exercised at 80-85 
percent of maximum heart rate. Following the eight weeks of training) 
fitness and blood lipids were reassessed. Allison found that both 
training groups failed to increase HDL-C above the control group, and 
both training groups showed a slight decrease in HDL-C (5 mg/dl). CR 
fitness was increased for both exercise groups, but had no significant 
relationship to HDL-C. 
The complex nature of the factors involved in lipid metabolism 
require stringent controls to effectively define exercise effects on 
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HDL-C. upon examination of the research related to the exercise-HDL-C 
relationship, it was evident that no clear conclusion could be made. 
Obvious differences in HDL-C levels are well demonstrated in extreme 
groups; however, further research is necessary to clarify exercise 
effects on HDL-C. 
Related Research 
Dietary data related to HDL-C has been variable and inconsistent. 
Some studies have demonstrated increased HDL-C with dietary intake of 
polyunsaturated and saturated fat (37-38). However, conflicting evi-
dence has not been supportive of this relationship (39). Further infor-
mation and research on the effect of dietary intake of fat on HDL-C is 
needed to clarify this relationship. 
The effect of alcohol consumption on HDL-C has been fairly well 
established. A large number of studies have demonstrated a positive 
correlation between alcohol consumption and HDL-C (39-42). Therefore, 
it is assumed that alcohol consumption will have a positive effect on 
HDL-C. 
The relationship of cigarette smoking to HDL-C has been extensively 
studied. It is generally accepted that cigarette smoking has a negative 
effect on HDL-C levels (41, 43-45). Therefore, for the purposes of this 
study cigarette smoking will be assumed to lower HDL-C levels. 
CHAPTER III 
METHODS AND PROCEDURES 
This chapter describes the methods and procedures employed in this 
investigation. 
Research Design 
A schematic presentation of the experimental design is shown in 
Figure 1. Seventy-two volunteer subjects were recruited from the Tulsa 
area. Tbree weeks prior to the training period all subjects underwent a 
medical screening and Tl laboratory studies. Tl tests collected pre-
treatment dat~ on cardiorespiratory fitness, blood lipids, and body com-
position. Following the Tl testing, the 72 subjects were randomly 
assigned to either the experimental group or the non-exercising control 
group. Thirty-six sub.jects were assigned to each group, and the 12-week 
treatment period of organized exercise was begun for the experimental 
group. 'Within three weeks of the termination of the treatment period, 
94.4 percent (34/36) of the subjects from the experimental group and 
. 
91.7 percent (33/36) i~£ the subjects from the control group were 
reassessed at the t2 laboratory studies. For the purposes of statist!-
cal analysis only subjects with complete data were studied. 
Subjects 
Subjects were recruited from the Tulsa area by an advertisement pub-
lished in a local newspaper and the distribution of a flier 
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published in a local newspaper and the distribution of a flier (see 
Appendix A). In order to be eligible for this study, subjects had to 
meet the following criteria: (1) male; (2) between 30 to 50 years of 
age; (3) "inactive" (i.e. exercising_less than three times per week over 
the prior six months); and (4) free of known CHD and symptoms of CHD; 
(5) willing to be randomly assigned to ei-ther the experimental group or 
the control groups. Assessment of physical activity revealed: (1) 77.8 
percent of the subjects indicated they had not engaged in exercise in 
the past six months; (2) 11.1 percent of the subjects indicated they had 
engaged in exercise occasionally; (3) 11.1 percent of the subjects indi-
cated they had engaged in exercise once each week. The activities of 
the latter group varied from tennis, raquetball, basketball, soccer and 
jogging. 
Before the subjects were permitted to participate in the study, an 
informed consent (see Appendix A) was signed by each subject detailing 
the design of the research project and the testing involved. No subject 
was under any obligation and retained the right to withdraw at any time. 
None of the subjects were excluded or withdrew from the study because of 
stipulations outlined in the informed consent. 
A medical screening was given to all subjects who met the eligibil-
ity criteria in the Human Performance Laboratory, Oral Roberts 
University. This test battery included a brief medical history (see 
Appendix A), a 12-lead resting electrocardiogram (ECG), a resting blood 
pressure, and a physician supervised graded exercise test (GXT). The 
purpose of this testing was to further screen out individuals with CHD 
or symptoms of CHD. The Bruce Treadmill Protocol (see Appendix B) was 
employed for the GXT, and subjects were instructed to perform to their 
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maximal endurance. Continuous monitoring of ECG was employed to deter-
mine the maximum heart rate of each subject. No subject was eliminated 
from the study as a result of underlying CHD or sym.ptons of CHD. 
Data 
Cardiorespiratory Fitness 
CR fitness was assessed on each subject at T1 and T2 by means of 
' . 
direct measurement of VOz during a Balke Treadmill Test (see Appendix 
. 
B). The Beckman Metabolic Measurement cart was utilized to measure VOz 
(36). The maximal heart rate achieved on the Bruce Treadmill Test was 
utilized to calcuiate a submaximal work load of 80 percent of maixmal 
heart rate range. The Balke Test was terminated when the subject reach-
ed their 80 percent of maximal heart rate range • 
. 
Maximal VOz was estimated by correlating each subjects heart 
• 
rate response to their measured VOz. Their maximal heart rate was then 
. 
used as a predictor of maximal VOz. Three parameters were used to 
assess the effects of 12 weeks of exercise on CR fitness: (1) VOz 
. 
measured at a heart rate of 150 on all subjects; (2) V02 measured at 80 
percent of maximal heart rate range on all subjects; and (3) estimated 
• 
maximal VOz. One subject in the experimental group could not be 
assessed on CR fitness at T2, therefore, only 33 subjects were used for 
statistical analysis of CR fitness data. 
Blood Lipids 
The major variable of interest in terms of the purpose of this 
study was HDL-C. To provide a more complete profile total cholesterol 
(TC) and triglycerides (TG) were assayed. These tests were performed on 
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all 72 subjects at T1, and 34 subjects in the experimental group and 33 
subjects in the control group at T2. Blood samples were drawn after a 
12-hour fast. Assays were performed at the Oklahoma City Lipid Research 
Clinic, which employs standard procedures of the Lipids Research Clinics 
Program (46). The method employed in the lipidassay was the heparin-
Mn2+ precipitation technique. One subject in the experimental group did 
not have sufficient quantity of plasma in this T2 blood sample to assay 
HDL-C; therefore, only 33 subjects were used for statistical analysis of 
HDL-C. 
Body Composition 
Body weight was assessed on all subjects at T1 and T2. Percent 
body fat was estimated by the skinfold procedure of Durnin and Rahaman 
(47). A trained technician measured skinfold sights for all subjects. 
Because of the technique involved, if the technician was unable to 
. locate the skinfold sight or if the skinfold was tight and measurement 
unreliable, the technician marked the data invalid. For the purposes of 
statistical analysis 28 subjects in each group had valid skinfold 
measures. 
Percent body fat was also assessed by hydrostatic weighing tech-
nique. The procedure of Siri was utilized in the determination of per-
cent fat (48). Once again a trained technician was used to assess 
hydrostatic weight. Because of the technique, the validity of the 
measurement was dependent on the ability of the subject to perform the 
procedure. Certain subjects had difficulty performing the procedure 
underwater; therefore, their data was marked invalid by the technician. 
For the purposes of statistical analysis 27 subjects in the experimental 
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group and 26 subjects in the control group had valid hydrostatic weigh-
i ng measures. 
Treatment Protocols 
Experimental Group 
Subjects in the experimental group were enrolled in special classes 
·, 
of the Oral Roberts University Adult Aerobic Fitness Program. These 
classes were conducted by the author and met for the 12-week treatment 
period. The classes met for one hour, three times per week. The first 
class met Monday, Wednesday, and Friday evening_, and the second class 
met on Tuesday, Thursday, and Saturday mornings. 
Each subject was given an individual exercise prescription based on 
the position statement of the American College of Sports Medicine (49). 
The maximal heart rate achieved on the medical screening and the resting 
heart rate (HR) on the 12-lead EGG were utilized to determine heart rate 
ranges for exercise intensities. The Karvonan Formula (49) was used to 
determine the exercise intensities for each subject: 
(Maximum Heart Rate - Resting Heart Rate) Percent of Heart Rate 
range + Resting Heart Rate = Exercise Intensity 
The following exercise progession was employed to allow the subjects to 
progress to a target intensity of 75 percent of heart rate range, and a 
duration of 30 minutes or more of continuous walking or jogging (see 
Table I). 
All subjects were instructed in monitoring their heart rate inten-
sities by carotid palpation. Heart rate intensities were monitored 
periodically during the activity by counting the number of heart beats 
in ten seconds and then multiplying the number of beats by six. All 
intensities were recorded in their activity log (see Appendix A). 
Week 
1 60% 
2 60% 
3 65% 
4 70% 
5 75% 
TABLE I 
EXERCISE PROGRESSION 
Intensity 
Heart Rate Range 
Heart Rate Range 
Heart Rate Range 
Heart Rate Range 
Heart Rate Range. 
Duration 
10-20 minutes 
20-25 minutes 
25-35 minutes 
25-35 minutes 
30-40 minutes 
17 
Each subject in the experimental group was given an individual 
activity log. The activity log contained the subject's exercise pre-
scription and recording forms for activity data. The subjects were 
instructed in the proper methods for recording the information over the 
12-week treatment period. Subjects indicated the type of activity 
in which they engaged, the intensity of the activity (by heart rate), 
and the duration of the activity. In order to gain maximal improvements 
in CR fitness, the subjects were encouraged to exercise outside of the 
organized classes as well and record all information in the activity 
log. 
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Control Group 
The subjects in the control group were instructed to refrain from 
exercise as much as possible over the 12-week treatment period. The 
author contacted each control subject bimonthly by phone to quantify any 
activity in which they may had engaged. At the· termination of the 
treatment period, 69.7 percent (23/33) of the control subjects had not 
engaged in any exercise over the previous 12 weeks. A total of 24.2 
percent (8/33) of the control subjects indicated they participated in 
some type of exercise over the 12-week treatment period. These activ-
ities varied from downhill skiing, golf, soccer, softball, walking, and 
jogging. All subjects in this category engaged in these activities 
less than four times over the treatment period. The final group of 6.1 
percent (2/33) of the control subjects indicated they engaged in tennis 
or raquetball once per week over the twelve week treatment period. 
Diet 
Diet was assessed during the T1 studies by means of a questionnaire 
(see Appendix A). The purpose of this data collection was not to pro-
vide quantitative data on dietary intake, but rather, to identify indi-
viduals who demonstrated extreme dietary patterns. After reviewing the 
data no subject demonstrated extreme dietary patterns. All subjects 
were instructed not to intentionally alter their eating habits over the 
course of the study. During the T2 laboratory studies each subject was 
asked if they had altered their dietary patterns during the course of 
the study. No subject indicated that he had changed his diet. 
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Alcohol Consumption 
Alcohol consumption was also assessed by the aforementioned ques-
tionnaire. The questionnaire provided ~dentification of the following 
subgroups: (1) non-drinkers (n = 24); (2) light drinkers (<1 -3 drinks 
per month of either beer, wine, or liquor) (n = 23); (3) _moderate drink-
ers (1 - 6 drinks per week of either beer, wine, or liquor (n = 16); and 
(4) heavy drinkers (1 - 3 drinks per day of either beer, wine, or liquor) 
(n = 4). Ideally, a multivariate matrix would be appropriate to analyze 
alcohol consumption data in relation to physical activity and HDL-C; 
however, this statistical process was unavailable. Therefore, a simple 
t-test was used to determine if a statistically significant difference 
existed between mean HDL-C levels in non-drinkers versus drinkers. 
Smoking History 
Smoking status was assessed during Tl laboratory studies by means 
of a questionnaire (see Appendix A). A total of nine subjects indicated 
they were current cigarette smokers, the remainder of the subjects indi-
cated they were non-smokers. As was mentioned earlier, a multivariate 
approach more appropriately analyzes the effect of cigarette smoking in 
relation to other variables (exercise, alcohol consumption, HDL-C, 
etc.). However, since this option was not available a t-test was run 
between non-smokers and smokers to test for significant differences in 
mean HDL-C levels. 
Statistical Analysis 
Statistical analysis of the data collected in this investigation 
was run at the Oral Roberts University computer center using a Data 
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General Computer (AOS). Several statistical procedures were used to 
evaluate the data. The analysis of covariance was used to adjust for 
the differences in the means between the experimental and control groups 
and to determine the effects of treatment from pretesting to post-
testing. Dependent t-tests were run to determine treatment effects 
within the groups. Independent t-tests-were run to determine differ-
ences between the mean HDL-C levels of non-drinkers and drinkers, and 
non-smokers and smokers. Finally, a Pearson Product-Moment correlation 
was run to determine the relationships between physical activity, CR 
fitness, and HDL-C (SO). 
------
CHAPTER IV 
RESULTS AND DISCUSSION 
Age and height assessed at Tl studies are found in Table II. The 
mean age for the experimental and control groups were 40.8 years and 
40.6 years, respectively. The mean height for experimental and control 
groups were 70.4 inches and 70.2 inches, respectively. Independent t-
test showed no significant differences between the groups. 
TABLE II 
AGE (YEARS) &~D HEIGHT (INCHES) FOR THE EXPERIMENTAL 
AND CONTROL GROUPS 
Standard 
n He an Deviation Range 
Age 
Experimental 34 40.8 ± 4.7 30 - 50 
Control 33 40.6 ± 5.8 30 - 49 
Height 
Experimental 34 70.4 ± 1.8 67.5 - 74 
Control 33 70.2 ± 3.2 63 -77 
21 
t-Ratio 
.13 
.25 
Analysis of Covariance of Pretreatment and 
Posttreatment Data · 
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After the 12-week treatment period, pretraining and posttraining 
data underwent statistical analysis using the analysis of covariance. 
The results of the body composition data for the experimental and con-
trol groups are found in Table III. Both groups demonstrated a reduc-
tion in body weight. The reduction for the experimental group was more 
pronounced than that of the control group, but not statistically sig-
nificant. Percent body fat assessed by skinfolds was lower for both 
groups, but the experimental groups was significantly lower (p < .05). 
Percent body fat assessed by hydrostatic weighing was 1 percent lower in 
the experimental group and .2 percent higher in the control group. How-
ever, there was no statistically significant difference between the 
groups. 
Analysis of covariance of the blood lipid data is found in Table 
IV. No statistical significance was found between the experimental and 
control groups on total cholesterol, trigycerides, HDL-C, and HDL-C per-
cent. Both groups demonstrated a reduction in total cholesterol; how-
ever, the reduction for the experimental groups was more pronounced than 
the control group. Trigycerides were virtually unchanged for the con-
trol group, but a slight reduction was noted for the experimental group. 
The experimental and control groups showed a reduction in HDL-C, 2.97 
(mg/dl) and 3.24 (mg/dl), respectively. The experimental group 
increased .1 percent, and the control groups decreased 1.1 percent in 
HDL-C percent; but, no significance was found between the groups. 
Finally, the analysis of covariance was run on the CR fitness 
parameters of: (1) vo2 HR 150; (2) V02 80 percent HR; and (3) estimated 
TABLE III 
ANALYSIS OF COVARIANCE OF BODY COMPOSITION DATA 
% Body Fat % Body Fat 
Experimental n Weight (lbs) n (Skinfolds) n (Hydrostatic Weight) 
T1 Mean 34 190.1 28 22.3 27 22.5 
Standard Deviation ± 31.0 ± 5.5 ± 5.6 
Range 132.5 - 271.5 14.8 - 27.1 7.4 - 32.8 
T2 Mean 34 185.9 28 20.5 27 21.8 
Standard Deviation ± 31.0 ± 7.6 ± 6.3 
Range 131 - 266 10- 27.9 7.9 - 32.8 
-
Control 
T1 Mean 33 185.5 28 22.7 26' 21.8 
Standard Deviation ± 24.3 ± 6.3 ± 4.4 
Range 144 - 244.5 14.8 .. 27.5 ' 14.6 - 32.8 
T2 Mean 33 183.6 28 21.8 26 . 22 
Standard Deviation ± 23.3 ± 6.3 ± 3.8 
Range 144.25 - 241.5 15.8 - 27.8 15.3 - 29.4 
F Ratio 2.99 4.05 3.07 
Critical F 4.00 4.00 4.00 
(.05 level) 
--~-~---- -~-------------
N 
w 
Experimental n 
T1 Mean 34 
Standard Deviation 
Range 
T2 Mean 34 
Standard Deviation 
Range 
-
Control 
T1 Mean 33 
Standard Deviation 
Range 
T2 Mean 33 
Standard Deviation 
Range 
F Ratio 
Critical F 
(.OS level) 
TABLE IV 
ANALYSIS OF COVARIANCE OF BLOOD LIPIDS 
TC(mg/dl) n TG(mg/dl) n HDL-C(mg/dl) 
204.9 34 111.5 33 46.2 
± 30.5 ± 60.7 ± 10.6 
146 - 264 45 - 386 24 - 75 
190.1 34 105.6 33 43.2 
± 30.7 ± 53.5 ± 8.5 
135 - 285 37 - 267 27 - 66 
204.5 33 129.3 33 45.7 
± 38.5 ± 76.5 ±11. 5 
133 - 342 45 - 340 26 - 79 
196.5 33 130.6 ' 33 42.5 
± 33.0 ± 85.7 ±8.9 
120-284 53 - 365 27 - 69 
2.25 .944 .142 
4.00 4.00 4.00 
n 
33 
33 
33· 
33 
HDL/TC X100 (%) 
23 
± 6.2 
10 - 38 
23.1 
± 5.7 
13 - 36 
23.5 
± 8.6 
10 ~ 49 
22.4 
± 5.7 
10 - 41 
2.06 
4.00 
N 
+>-
2S 
. 
V02 maximum. The results of the CR fitness data are found in Table V. 
On all three parameters, the experimental group was sigificantly higher 
in fitness following the 12-week treatment period (p < .01) than the 
control group. The experimental group demonstrated a 19.2 percent 
• increase in VOz measured at a heart rate of 1SO, a 19.1 percent increase 
. 
in V02 measured at 80 percent of maximum heart rate range~ and a 20.3 
. 
percent increase in estimated VOz maximum. Comparatively, the control 
group demonstrated an increase in fitness of 4.S percent, 7.1 percent 
and 7.6 percent, respectively. 
Dependent t-Tests Within Groups 
Dependent t-tests were run to assess the effects of 12-week treat-
ment period within the groups (T1-T2). The statistical results for the 
expermiental group are found in Table VI. The experimental group demon-
strated a significant reduction in weight and percent body fat by skin-
folds (p < .001). The experimental group also showed a significant 
reduction in total cholesterol and HDL-C, p < .001 and p < .01, respec-
tively. Cardiorespiratory fitness assessed at a heart rate of 1SO, 80 
percent of heart rate range, and estimated maximum were significantly 
higher on all parameters (p < .001). 
The statistical results of the dependent t-tests run for the con-
trol group are found in Table VII. The control group also demonstrated 
a significant reduction in percent body fat assessed by skinfolds 
(p <.Ol). The control group also demonstrated significant reductions in 
total cholesterol and HDL-C, p <.OS and p (.01, respectively. The con-
trol group demonstrated increased CR fitness at estimated maximum (p < 
.001) and at a heart rate of lSO (p < .OS). No significant increase in 
TABLE V 
ANALYSIS OF COVARIANCE TABLE OF CARDIORESPIRATORY FITNESS 
. • . . • • VOzHR 150 VOzHR 150 VOz HR 80% HR VOz HR HR Est. VOz Max Est. VOz Max 
Experimental n (ml2/kg•min-1) (L02/min) (mlo2/kg•min-1) (Lo2/min) (mlo2/kg•min-1) (Lo2/min) 
T1 Mean 33 24.5 2.10 26.7 2.28 32 2.73 
Standard 
Deviation ± 3.7 ± .36 ± 4.0 ± .38 ± 4.7 ± .43 
Range 18.5 - 34 1.43 - 2.65 20.3- 34.7 1.48 - 2.89 23.3 - 43.2 1.96 - 3.43 
T2 Mean 29.2 2.44 31.8 2.66 38.5 3.22 
Standard 
Deviation ± 4.1 ± .41 ± 4.7 ± .46 ± 6.0 ± .59 
Range 22.7- 38.9 1.6 - 3.22 23- 42.1 1.79- 3.68 28.2 - 50.9 2.01 - 4.46 
-
Control 
T1 Mean 33 24.4 2.05 26.6 2.24 31.5 2.65 
Standard 
Deviation ± 3.3 ± .42 ± 3.1 .± .39 ± 4.3 ± .so 
Range 18.6 - 30.9 1.4 - 3.25 21 - 32.2 1.63 - 3.35 24.5 - 40.9 1.85 - 3.91 
T2 Mean 25.5 2.14 28.5 2.37 33.9 2.83 
Standard 
Deviation ± 3.8 ± .46 ± 3.9 ± .45 ±4.9 ± .55 
Range 17.4 - 35.8 1.41 - 3.45 22.4- 37.7 1.65 - 3.5 26.8- 46.9 1.9 - 4.15 
F Ratio 22.3 18.7 11.2 16.9 20.2 18.4 
Critical F 7.08 7.08 7.08 7.08 7.08 7.08 
(.OS level) 
N 
0\ 
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TABLE VI 
DEPENDENT t-TEST FOR EXPERIMENTAL GROUP (T1-T2) 
Body Composition 
Weight 
% Body Fat (Skinfolds) 
% Body Fat (Hydrostatic 
weight) 
Blood Lipids 
Total Cholesterol 
Triglycerides 
HDL-C 
HDL-C/TC x 100 
Cardiorespiratory Fitness 
VOz HR 150 (mloz/kg•min-1) 
• VOz HR 150 (LOz/min.) 
VOz 80% HR (mloz/kg•min-1) 
VOz 87% HR (LOz/min.) 
VOz Est. Max (mloz/kg•min-1) 
. 
VOz Est. Max (LOz/min.) 
N.S. - No significance 
Significance Level 
5.40 .001 
5.34 .001 
1.84 N.S. 
3.93 .001 
0.69 N.S. 
3.51 .01 
0.24 N.S. 
7.86 .001 
7.52 .001 
8.61 .001 
7. 71 .001 
8.74 .001 
8.11 .001 
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TABLE VII 
DEPENDENT t~TEST FOR CONTROL GROUP (T1-T2) 
Body Composition 
Weight 
% Body Fat (Skinfolds) 
% Body Fat (Hydrostatic 
weight) 
Blood Lipids 
Total Cholesterol 
Triglycerides 
HDL-C 
HD1-C/TC x 100 
Cardiorespiratory Fitness 
VOz HR 150 (mloz/kg•min-1) 
.. 
V02 HR 150 (102/min.) 
VOz 80% HR (mloz/kg•min-1) 
. 
VOz 87% HR (LOz/min.) 
VOz Est. Max (mloz/kg•min-1) 
. 
VOz Est. Max (102/min.) 
N.S. - No significance 
t-Ratio Significance Level 
1. 89 . N.S. 
3.51 
0.52 - N.S. 
2.54 .05 
0.13 N. S • 
• 01 
1.58 N.S. 
2.32 .05 
2.19 .05 
N.S • 
4.06 .001 
4.57 .001 
4.85 .001 
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CR fitness was found at 80 percent of heart rate range. 
Physical Activity Data 
Physical Activity Data For the Experimental Group 
The physical activity data for the experimental groups is found in 
Table VIII. Data was collected in four major areas: (1) frequency of 
activity; (2) intensity of activity (perce~t of heart rate range); (3) 
duration of activity (minutes); and (4) distance run or walked (miles). 
The mean frequency of run-walk activities was 27.2 workouts, which aver-
ages to 2.3 workouts per week. The average intensity per workout was 
73.3 percent of heart rate range. The average duration of a run-walk 
workout was 31.8 minutes. The total distance run or walked ranged from 
7.66- 150.63 miles, the mean was 85.2 miles. The group averaged 7.1 
miles per week, and averaged 3 miles per run-walk workout. 
Relationships of Cardiorespiratory Fitness and 
HDL-C to Physical Activity 
The Pearson Product-Moment correlation was run to characterize the 
relationships of CR fitness and HDL-C to physical activity. The results 
of these tests are found in Table IX. The change (T2-T1) in estimated 
. 
maximum VOz, HDL-C, and HDL-C percent also demonstrated a significant 
positive correlation with miles per week run-walked, p < .05, p ( .05, 
and p ( .01, respectively. 
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TABLE VIII 
PHYSICAL ACTIVITY DATA FOR EXPERIMENTAL GROUP DURING 
THE 12-WEEK TREATMENT PERIOD (n = 34) 
S,tandard 
Mean Deviation Range 
Frequency 
All Activities 28.3 ± 8.0 4 - 47 
Run-walk 27.2 ± 7.7 4 - 43 
Run-walk/week 2.3 ± .64 .33 - 3.58 
Intensity 
All Activities (% HR Range) 72.4 ± 7.3 38.9 - 82.1 
Run-walk (% HR Range) 73.3 ± s.s 56.2 - 82.1 
Duration 
All Activities (minutes) 909.2 ±313.8 94.5 - 1591.53 
Run-walk (minutes) 873.5 ±312.6 94.5 - 1506.53 
Per Workout Run-walk (minute) 31.8 ± 5.7 15.85 - 45.05 
Distance 
Total Miles Run-walk 85.2 ± 34.8 7.66 - 150.63 
Miles Run-walk/week 7.1 ± 2.9 .64 - 12.55 
Miles Run-walk/workout 3.0 ± .68 1. 85 - 4.86 
TABLE IX 
RELATIONSHIPS OF CARDIORESPIRATORY FITNESS AND HDL-C TO PHYSICAL ACTIVITY: 
PEARSON PRODUCT-MOMENT CORRELATION 
Correlation Significance 
12-Week Change For: Control (n = 33) Exercise (n = 33) vs. miles/week Level 
--
. 
Est. Max VOz 
(mloz/kg•min-1) 2.42 6.46 .39 .05 
HDL-C (mg/dl) -3.25 -2.97 .41 .05 
HDL-C/TC X 100 (%) -1 .2 .45 .01 
w 
,_. 
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Statistical Analysis of Smoking and Alcohol 
Consumption 
To determine whether HDL-C levels were effected by smoking and 
alcohol consumption, independent t-t~sts were run. The results of 
of statistical analysis of smoking and alcohol consumption are found in 
-
Tables X and XI. Non-smokers versus smokers did notdemonstrate signi-
ficantly different HDL-C levels. Independent t-test between non-
drinkers and drinkers were run, but no significant difference was found 
between the groups. 
TABLE X 
INDEPENDENT t-TEST: EFFECT OF SMOKING ON HDL-C LEVELS (T1) 
Smoking Data 
Non-Smokers 
( n = 58) 
Smokers 
(n = 9) 
Mean 
(mg/dl) 
45.6 
47.9 
N.S. - Significance 
Standard Deviation 
(mg/dl) 
±11.0 
± 11.4 
Discussion 
t-Ratio 
-.58 
Significance 
Level 
N.S. 
The main variable of interest in terms of this investigation was 
HDL-C. When this data was analyzed using the analysis of covariance, no 
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significant difference in HDL-C was found from pretreatment to post-
treatment between the groups. However, when the 'changes (T2-Tl) in HDL-
C and HDL percent were correlated to the miles run-walked per week in 
the experimental group, a significant positive correlation was found. 
This suggests that a mechanism is at work in the lipid metabolism to 
improve the HDL-C profile through physical activity. The·exact nature 
of this mechanism is unclear, but an apparent undetermined threshold of 
physical activity improves the HDL-C profile. 
TABLE XI 
INDEPENDENT t-TEST: EFFECT OF ALCOHOL CONSill1PTION 
ON HDL-C LEVELS (Tl) 
Smoking Data 
Non-Drinkers 
(n = 24) 
Mean 
(mg/dl) 
44.3 
Drinkers 46.8 
(n = 43) 
N.S. - No Significance 
Standard Deviation 
(mg/dl) 
± 9.7 
± 11.6 
t-Ratio 
-.90 
Significance 
Level 
N.S. 
Because of the multiplicity of variables interacting during the 
treatment period, several factors may have confounded the effect of 
physical activity on the absolute value of HDL-C. The reductions noted 
in total cholesterol in the experimental and control groups undoubtedly 
had an effect on HDL-C, since HDL-C is a subfraction of total choles-
terol. Also, the reductions in weight and percent body fat may indi-
rectly reflect changes in dietary patterns in both groups. Exercise, 
however, undoubtedly played a major role in weight and percent fat 
reduction in the experimental groups. The duration of the treatment 
period may not have been sufficiently long enough to demonstrate pro-
nounced differences in HDL-C in primarily sedentary individuals. 
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Both the experimental group and the control group demonstrated sig-
nificant improvements in CR fitness. The control group may have improv-
ed as a result of the learning process. The improvements noted in the 
experimental groups were a result of the exercise training and to a 
lesser degree the learning process. 
Other studies have demonstrated significantly lower HDL-C levels in 
cigarette smokers and significantly higher HDL-C levels in those who 
consume alcohol. These results did not surface in this investigation. 
No significant difference in HDL-C was found in non-smokers versus 
smokers and non-drinkers versus drinkers. 
CHAPTER V 
CONCLUSIONS AND RECOMMENDATIONS 
Conclusions 
The purpose of this study was to determine the effect of 12 weeks 
of exercise training on plasma high density lipoprotein cholesterol in 
men aged 30-50. On the basis of the analysis covariance, no significant 
difference in HDL-C levels was demonstrated as a result of 12 weeks of 
exercise training. Therefore, the null hypothesis was accepted. 
Dependent t-tests run on T1 and T2 data for both groups demonstrated a 
significant reduction in HDL-C. However, significant positive correla-
tions were found between changes (T2-T1) in HDL-C and HDL-C percent, and 
miles run-walked per week for the experimental group. Although no sig-
nificant increase in the absolute value of HDL-C was demonstrated, exer-
cise had a positive effect on HDL-C profiles. 
Recommendation for Further Study 
1. A longitudinal treatment protocol should be implemented to 
study the effect of regular exercise on HDL-C. 
2. Attention should be given to specific thresholds of physical 
activity, in this case miles per week, in relation to improved 
HDL-C profiles. 
3. Several experimental and control groups should be used in 
studying the exercise-HDL-C relationship to better characterize 
35 
treatment effects. 
4. Better controls and assessment of diet, alcohol consumption, 
and cigarette smoking are needed to characterize more 
accurately exercise effects on lipid metabolism. 
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FOR MEN ONLY 
Here's your chance to have a physical evaluation and a 12-week exercise 
program at the ORU Human Performance Labaoratory and Aerobics Center. 
Participation is free and at no obligation. 
We are looking for eligible men (30-50-year-olds) who would like to 
receive important health and fitness information .about themselves and 
enter an organized fitness program (either immediately or in the near 
future), while assisting in important scientific research. 
This is a special research project to be conducted by the ORU Human 
Performance Laboratory to study the effectp of regular exercise on blood 
cholesterol. 
To be eligible you must be: 
Male (30-50) 
Not engaged in a regular exercise program 
Free of known cardiovascular disease or any other 
condition which places one at increased risk 
with exercise (the initial screening tests will 
evaluate this) 
Willing to be randomly assigned to either an 
organized exercise group or a control group for 
approximately 12 weeks. 
kper~-~rgan!~ed ~·-1/ Group Exercise Program \ 
Medical Lab Studies I / " .. -
Recruitment----:;.. Screening~ & Randomization TREATMENT PERIOD Lab Studies II 
. ~ Control No organizell -?-I 
The Schedule: 
Group lxerciae ProKram 
Medical Screening Tests: late January-early February 
Lab Studies I: mid-February 
"Treatment Period": late February to Late May 
Lab Studies II: completed early June 
During the treatment period, those assigned to the experimental group 
will have special classes, 3 days a week, in the ORU Aerobics Center. 
Indiviually prescribed exercise programs will emphasize aerobic or car-
diorespiratory conditioning, with walking and jogging the principal 
activities. Those assigned to the control groups wil be given the oppor-
tunity to take part in an organized exercise program free of charge, at 
the close of the testing period. Exercise class will tentatively be 
held on Tuesdays and Thursdays at 6 a.m. and on Saturdays at 9 a.m., 
subject to group preference. 
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The following studies will be made and the results of your tests will be 
made available to you: 
Medical Screening: 
Lab Studies I: 
Lab Studies II: 
Brief medical history, resting electro-
cardiogram (ECG), resting blood pressure 
(BP), pulmonary function, exercise tolerance 
(treadmill test with ECG and BP monitored) 
Blood lipids (cholesterol, HDL-Cholesterol, 
trygycerides, and perhaps others); body com-
position (pe~cent fdat by both underwater 
weighing and skinfold estimates); cardio-
respiratory fitness (oxygen consumption dur-
ing treadmill exercise), coronary risk 
profile 
Repeat of all tests in Lab Studies I 
If you will participate or would like more information,contact Jim 
Freyman or Dr. James Schwane, Human Performance Laboratory, Oral Roberts 
University, 492-6161, ext. 2415 or 2416. 
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TULSA WORLD, SUNDAY, MARCH 1, 1981 
FOR MEN ONLY--Over the next several months, the Oral Roberts Univer~ity 
Human Performance Laboratory will be conducting a research project to 
study the effects of exercise training on blood cholesterol. Subjects 
who meet this criteria are needed: men~ 30-50 years of age, not pre-
sently engaged in a regular exercise program, free of known cardio-
vascular disease, and willing to be randomly assigned to an exercise or 
control group for the period of study. This project provides an oppor-
tunity for men who meet our criteria to have thorough fitness evalua-
tions and an organized exercise program for 12 weeks. Participation is 
free and at no obligation. For further information contact Jim Freyman 
or Jim Schwane, 492-6161 ext. 2415 or 2416. 
ORU HUMAN PERFORMANCE LABORATORY 
PERSONAL MEDICAL HISTORY 
SEX: M. F 
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DATE NAME ___________________________ AGE 
-----
ADDRESS 
----~(rs~t-r-ee~t~)~--------~~(~c7i-ty~)~------~(-st_a_t_e~)----~(rz~i~p) 
PHONE (HOME) 
----------
(WORK) ---------
PHYSICIAN'S NAME 
-------------------------------
ADDRESS 
--~----~~----------~---~------~~-~-----~~ (street) (city) (state) (zip) 
PHONE 
-------------------
DATE OF LAST MEDICAL EXAMINATION 
-------------------------------
PLEASE ANSWER THE FOLLOWING AS ACCURATELY AS POSSIBLE. 
1. Have you ever had a heart attack? YES NO 
-----
If "yes," explain (e.g. when, etc.) ------------------------
2. Have you ever had heart surgery? YES 
---
NO 
---
If "yes," explain (e.g. when, type, etc.) 
-----------------
3. Do you ever experience chest pain? YES NO 
---'--
If "yes," check the items which apply: 
a) Intensity-- slight moderate severe 
b) Frequency-- frequent (at least once a day) 
moderately frequent 
infrequent (only a few times each month) 
c) Duration-- pains lasts less than 5 minutes 
pain lasts 5 minutes or longer __ _ 
d) Relation to activity-- pain occurs at rest 
pain occurs only with exertion __ __ 
pain is unrelated to activity 
e) Do you take medication to relieve chest pain? YES NO 
If "yes," list medication(s) -----------------------
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4. Are you aware of any other heart related problems? 
a) murmer b) palpitations c) ECH abnormalities 
d) other (explain) 
-----------------------------------------------
5. Please check any of the following which may apply to you. 
6. 
7. 
8. 
a) high blood pressure 
b) low blood pressure 
c) diabetes 
---
~) high blood trigycerides 
f) obesity 
g) smoking 
d) high blood cholesterol h) sedentary lifestyle 
Do you ever experience dizziness? YES NO 
If "yes," explain 
Do you ever experience shortness of breath? YES NO 
If "yes," explain 
Do you ever experience calf pain when walking short distances? 
YES NO 
9. Do you experience any other physical disorders which may effect the 
type or amount of exercise in which you should participate (e.g. back 
problems, knee or ankle injuries, etc)? If so, explain 
---------------
SIGNATURE DATE 
--------------------------------- ---------------
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EXERCISE PRESCRIPTION 
NAME Tu. Th. S. AM / M. W. F. PM 
-------------------------------
WEEK 1 Intensity 60% Duration 10-20 minutes 
60% Heart Rate 
----
WEEK 2 Intensity 60% Duration 20-25 minutes 
60% Heart Rate 
----
WEEK 3 Intensity 65%n Duration 25-35 minutes 
65% Heart Rate 
----
WEEK 4 Intensity 70% Duration 25-35 minutes 
70% Heart Rate 
----
WEEK 5 Intensity 75% Duration 30-40 minutes 
75% Heart Rate 
----
Name 
EXERCISE -- HDL STUDY 
c 
Social Security No. 
Age---- Birth Date ------------------------ Sex: Male/Female 
In the past 6 aonths, have you exercised more .than two times per week on a regular 
basis? Yes/No If yes/what activities? 
Have you ever participated in a regular exercise program (YMCA, Fitness Center, 
Hospital, etc) Yes/No If yes/ what program? · When did you 
participate? How long did you participate? ----~----
Were you an athlete in High School? Yes/No What sport(s)? 
How long did you participate? 
Were you an athlete in College? Yes/No What sport(s)? 
How long did you participate? 
Physical Activity Comments: 
Have you ever had a heart attack? Yes/No 
any other heart related problems (murmur, 
Do you have high blood pressure? Yes/No 
Are you taking any aedications? Yes/No 
Medical Assessment 
Resting 12-Lead ECG 
Resting blood pressu~r~e-------------
Treadmill GXT -----------------------Result~: 
Chest Pain? Yes/No Are you aware of 
palpitations, etc.)? 
If yes/please list medication(s): 
Exercise Prescription 
Max Heart Rate (HR) 
90% of Max. HR 
SO% of Max. HR ------------
70':(. of Max. HR --------------
Group: Experimental ------------------------Phone NWIIber: llM Control ---------------------------WK 
AH/~PH~--------------------nDa~y Calling Time: ---------------------------
Body Composition 
Pulmonary Function 
R~sting blood pressure 
12-hr f~sting blood sample 
Treadmill GXT 
Co~~~~~~enu: 
Physical Activity Check: 
Wk 5 Wk 6 
Wk 11 Wk 12 
Co11111ents: 
Lab Test 1 
WI< 1 
Wk 7 
Wk13 
Wk2 
Wk8 
Wk 14 
Lab Test 2 
Wk 3 
Wk 9 
Wk4 
Wk 10 
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SMOKING HISTORY 
Social Security No. 
·Name-----------------------------
Test Date Age __ _ Birth Dat" 
INSTRUCTIONS: Please answer all questions as accurately and co~pletely as possible. 
1. Have you ever smok"d cigarettes, cigars, or pipes? Yes No 
If you an&;;r to #1 is No, the questionnaire is complete/If yes, Proceed. 
2. At what age did you begin to smoke? 
3. How many years have you smoked on a r"gular basis? 
4. Do you saoke now? Yes 
If no, how long ago did you ·quit 
__ 1-2 years __ 2-5 years 
If your answer to question #4 is 
No 
~making? 0-3 months 3-12 months 
More-chan 5 years 
No, skip to question #9/If yes,. Proceed. 
5. Do you currently smoke cigarettes?· Yes No 
If so, how many cigarettes per day (on the average) do you currently smoke? 
1-10 ll-20 21-30 31-40 41-60 60+ 
6. Do you currently smoke cigars? y.,s No 
If •o, how many cigars per day (on the average) do you currently smoke? 
1 Z-3 4-6 7-10 more than 10 
7. Do you currently smoke a pipe? Yes No 
If so, how many pipefuls per day-con-the average) do you currently smoke? 
1 2-3 4-6 7-10 more than 10 
8. Have you ever quit smoking? Yes No 
If yes, how long ago did you quit smoking?"""" 0-3 months 3-12 months 
__ 1-2 years __ 2-5 years Moret:ilan 5 years 
If yes, how long did you quit smoking? e-3 eonths 3-12 months 
__ 1-2 years __ 2-5 years More than 5 years 
9. Describe your smoking history: For how many years of your life have you 
•moked? On the average over the years th•t you have amoked, how 
many ciga;;tt;s (cigars or pip.,s) have you saoked per day? 
cigarett"s per day 
cigars per day 
pipes per day 
10. w~t is the maximum number of cigarettes per day you have ever smoked? 
For how long a period did you smoke at this rate? When, in relation 
to the present, did you smoke at this rate? 
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DIET QUESTIONNAIRE 
Pleas~ indicate as accurately as possible the frequency with which you ~at the following foods. 
~ 2-3 _1_ 3-6 1-2 .1.:l_ Less than 
FOOD day day day week week aonth 1/aonth Never COIIDents 
MILK (whol~ 1 cu_p I 
2'--Fat 1 cup 
Non-Fat 1 cup ; 
CHEESE 
' 
Low-Fat I 
ICE CREAM 1 scoop I 
Ice Milk 1 scoop 
Milksbakl'/Malt 
Sherbl't/Yogurt 
' BUTTER 
MARGARINE I 
EGGS 
!fEATS: I : 
Hamburger i I 
Hotdogs 
' 
I 
Bacon/Sausag~ I 
Pork ! I 
Chicken I 
Turkey 
Fish l 
Shellfish 
Liver i 
Veal ., 
Lamb 
Luncheon Meats I I 
SOFT DRINKS: 
R~auhr 12 oz. can 
' Artificial sweetner I I 12 oz. can 
Other 
COFFEE: 
With su~ar 1 tsp. ! 
With crt!! am 
TEA: I i 
With sugar 1 tsp. _I_ 
With cream 
ALCOHOL: i I ' 
B~er 12 oz. can ! : 
' 
I 
Wine 1 alass I I i 
Liquor 1 shot I .l ! 
SWEETS AND MISCELLANEOUS: I J ! i 
Cakes/Pies ! 
Puddir~g/Gelatio 
Cookies l 
Jam/Jelly i 
Syrup/Honey_ 
Candy L J 
Pancakes/Waffles I 
Peanut Butter _I_ 
' 
" 
ORU HUMAN PERFORMANCE LABORATORY 
COMPOSI'lE DATA Study _________ _ 
NAME. _________________________ ___ 
SS#·---------- Sex: M F 
BIR'll!DATE I I RACE. __________ _ U.S. CITIZEK? Y II 
STATUS "AIX<IISSION" STATUS IW. CONSENT? Y 11 
QUESTIONNAIRE 
Personal History of CV Disease? ( I . I Y N --------------------
Family History of CV Disease? ( I I ) Y lf 
Smoking History ( I I ): CURRENT I FORMER I NEVER 
Physical Activity ( I I )•--------------------
RESTING CARDIOVASCULAR 
Resting HR 
Resting BP 
Resting ECG 
DATE TIME VALIDITY 
y N 
y N 
y N 
·nATA 
AN'll!ROPOMETRY ( I I ) Valid? Y .N PULMONARY FUNCTION ( I I 
Ht: em/in Vt: _____ .--"'kg..,l~l.:;,b Spirometer: P-B I O..M Valid? Y N 
SF: triceps. _____ -.::::mm= Position: Stand I Sit 
subscapula.r ______ ....,::lllll~l FVC(BT.PS) L 
suprailiac. _______ -.::::mm::. FEV-l(BTPS) L 
biceps. ________ _..mm::. RV(BTPS) L -( aeas, I est, 
B.D. (est,/ meas.) ·-----
" Fat ( est. I iaeas. ) •;__ ___ _ 
~ < I I -Tille: Valid? Y N Meds? ________________ _ 
Total Chol HDL,.c---- LilLc_-( meas. /est, m'----
Glucose. ____ _ Hematocrit. __ _ 
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. EXERCISE TEST ( / I - Time 1 Valid? Y N 
lit, kg/lb 
Test Duration 
PROTOCOL/MIN HR 
--
Protocol• Ergom. #__ Prev. 'I'M Exp? Y N 
llP 
j I 
I I 
I I 
I I 
I I 
I I 
I I 
I I 
I I 
I I 
I I 
I I 
I I 
I I 
I I 
I I 
I I 
I I 
I I 
I I 
_j I 
l I 
I I 
j I 
J j 
t. L 
I I 
I I 
11ot1vation. BEl.DW I AVG I ABOVE 
VE(BTPS) TV(BTPS) 
L/11IN ML 
-
I 
vo2(STPD) 
LIMIN ML/KGIMIN R 
--
-j-
-- ----
-- -- --
-- -- --
-- -- --
-- -- --
-- -- --
-- -- --
-- -- --
-- --· --
-- -- --
-- -- --
-- -- --
-- -- --
-- -- --
-- -- --
-- -- --
-- -- --
-- -- --
-- -- --
-- -- --
-- -- --
-- -- --
-- -- --
-- -- --
-- -- --
--
--[--
I 
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ACTIVITY LOG 
AME WEIGHT 
DATE: 
_1_1_ Intensity (HR) Duration · Distance (Laps/Miles) 
Activities: Running 
Run/Walk 
Walking 
Cycling 
Weight Lifting === 
Other 
DATE: 
_!_!_ Intensity (HR) Duration Distance (Laps/Miles) 
Activities: Running 
Run/Walk 
Walk.ing 
Cycling 
Weight Lifting = 
DATE: 
_!_/_ Intensity (HR) Duration Distance (Laps /Miles) 
Activities: Running 
Run/Walk 
Walking 
Cycling 
Weight Lifting === 
Other 
DATE:_/_/_ Intensity (HR) Duration Distance (Laps/Miles) 
Activities: Running 
Run/Walk. 
Walking 
Cycling 
M~fi~~t Lifting _ 
DATE: 
-'-'-
Intensity (HR) Duration Distance (Laps/Miles} 
Activities: Running 
Run/Walk 
Walking 
Cycling 
Weight Lifting = 
Other 
DATE: 
_/_/_ Intensity (HR) Duration Distance (Laps/Miles) 
Activities: Running 
Run/Walk 
Walking 
Cycling 
Weight Lifting = 
Other 
DATE: _1_1_ Intensity (HR) Duration Distance (Laps/Miles) 
Activities: Running 
Ru.n/Walk 
Walking 
Cycling 
Weight Lifting __ 
Other 
55 
ORU HUMAN PERFORMANCE LABORATORY 
INFORMED CONSENT for PARTICIPATION as a SUBJECT in the RESEARCH PROJECT 
"EFFECTS OF 12 WEEKS of EXERCISE TRAINING on PLASMA HIGH 
DENSITY LIPOPROTEIN CHOLESTEROL and APOPROTEINS 
A-I AND A-II in MEN AGED 30 - 50" 
NAME OF SUBJECT TELEPHONE NO. 
--------------------------------
ADDRESS BIRTHDATE: 
--------------------------------~------
MO. DAY 
PROJECT DESCRIPTION 
YEAR 
A. Purpose of the Project. The amount of cholesterol in and the protein 
composition of high density lipoproteins (HDL) in the blood are 
apparently related to risk of coronary artery disease (CAD), i.e., 
it is desirable to have high levels of HDL-Cholesterol (HDL-C). 
There is evidence that regular exercise increases HDL-C levels and 
thus lowers risk of CAD, but a cause-and-effect relationship has not 
been established. Therefore, the purpose of this study is to 
describe the effects of 12 weeks of aerobic exercise training on 
plasma HDL-C and certain HDL proteins (e.g., apoproteins A-I and A-
II) in a group of men aged 30-50 years. 
B. Research Methodolgy: All subjects will initially undergo medical 
screening tests: resting blood pressure and ECG, personal medical 
history, physician chest exam, and graded exercise test (GXT) with 
ECG and blood pressure monitoring. Results of these tests will be 
used to give the final medical clearance of subjects for vigorous 
exercise and participation in the project. Subjects will then 
undergo "lab studies I" (T1) to provide baseline data on cardio-
respiratory (CR) fitness, percent body fat (% fat), and blood lipids 
and lipoproteins. Following Tl, subjects will be randomly assigned 
to either an exercise or a control group. The exercise group will 
have organized aerobic conditioning classes for 12 weeks; the con-
trol group will have no such classes. After S-6 weeks of "treat-
ment," the blood studies and skinfold % fat measures will be 
repeated on all subjects. At the completion of the 12 weeks, all 
subjects will undergo "lab studies II" (T2), identical studies to 
those of T1, to documents any changes over the 12 weeks. 
Each subject will perform 3 exercise tests on a motor-driven tread-
mill, one at medical screening, one at Tl, and one at T2. All 3 
tests will involve gradual increases in exercise intensity at set 
time intervals. Intensities will be very low initially and will be 
increased by increasing treadmill speed and/or incline. The subject 
will e xercise to his volitional maximum on the medical screening 
test, and to about 90% of that level on the Tl and T2 tests. During 
the T1 and T2 exercise tests, the subject will breathe through a 
mouthpiece-valve assembly with a nose clamp in place for collection 
of expired air and determination of oxygen consumption. 
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For the blood studies, about 15 cc of blood will be sampled from a 
forearm vein. These studies require that the subject be ·in the 
fasted state, i.e., no food or drink other t-han water for the pre-
vious 12 hours. 
Percent fat will be estimated both from measurements of skinfold 
thickness and by underwater weighing. The subject will be weighed 
in a specially designed tank while completely submerged in water. 
Either before or after underwater weighing, residual volume of the 
lungs will be measured, since corrections for buoyancy of air in the 
lungs at the time of weighing must be made. The subject's under-
water weight will be taken at the point of maximal expiration (i.e, 
residual volume). The subject must hold this submerged maximal 
expiration state for only a few seconds, while scale weight is 
recorded. 
At both T1 and T2, data on past and current smoking status, alcohol 
consumption, dietary patterns, and regular physical activity will be 
obtained from each subject by questionnaire and interview. 
Subjects in the exercise group will be give_n a personal exercise 
prescription based upon their GXT results and following guidelines 
of American College of Sports Medicine. Exercise sessions will be 
held on Tuesday, Thursday, and Saturdays for 12 consecutive weeks. 
Each session will last about one hour, with time in each session 
allotted for warm-up, flexibility and strength exercises, aerobic 
conditioning (walking and jogging), and cool-down. Each subject 
will be given explicit instructions regarding the amount and kind of 
exercise he should do. A log of each subject's training activity 
will be updated each exercise session. 
Subjects in the control group will have no organized exercise ses-
sions and are expected to not alter their pre-study patterns of reg-
ular exercise. Each will be contacted weekly to update records of 
exercise engaged in. 
C. Potential Risks to Subjects. The possibility exists of certain 
changes occurring during the exercise tests or exercise sessions. 
These include abnormal blood pressure, fainting, disorders of heart 
beat, and in very rare instances, heart attack. With blood sampling 
by venipuncture, there is the possibility of bruising the arm, and 
rarely, of infection or clot formation. 
D. Benefits of the Research. This project will help to establish 
whether or not regular aerobic exercise lowers CAD risk by raising 
HDL-C. If HDL-C is raised with training in this study, as hypothe-
sized, this study will also elucidate specific conditions in which 
this effect occurs. Thus, clinicians will be armed with additional 
evidence of specific benefits of exercise and with concrete guide-
lines for prescribing such exercise. 
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WRITTEN CONSENT 
I, , have read in its entirety and 
----7(=P-r7in-t~i~n--y_o_u_r~f~u~l~l--n_a_m-e') ____ __ 
understand the "PROJECT DESCRIPTION" for the project "Effects of 12 Weeks 
of Exercise Training on Plasma High Density Lipoprotein Cholesterol and 
Apoproteins A-I and A-II in Men Aged 30-50. I have been informed, either 
by reading the "PROJECT DESCRIPTION" or from persons associated with the 
study above-described, of all physical and psy~;::hological risks, as well 
as medical side effects which may occur_ during the course of the study, 
and I agree to accept all disclosed risks or potential side effects. I 
realize that risks will be minimized in the following ways: 
1. Before undergoing any exercise tests, my medical history will 
be reviewed to determine if any condition is present which 
would indicate I should not submit to these tests. 
2. During the performance of the exercise test, a physician or 
trained observer will keep me under close surveillance by 
monitoring my pulse and electrocardiogram. 
3. I may stop any exercise test at my discretion. 
4. My assigned exercise program will be personalized (i.e., 
based on my exercise tolerance as indicated by the exercise 
tests), and I will be observed by trained personnel during 
exercise sessions. Pulse rate will be frequently checked 
to assure appropriate exercise intensities. 
5. Emergency equipment and trained personnel will be available 
during exercise testing and training sessions to deal with 
unusual situations which may arise. 
6. Blood sampling will be performed by trained phlebotomists 
under medical supervision, using aseptic techniques. 
I have been told that Oral Roberts University, like virtually all other 
universities in the United States, does not have a mechanism for compen-
sation of the injured research subject; therefore, I understand that I 
canno look to any such mechanisms to receive financial remuneration for 
any such injuries resulting from my participating in this research 
project. 
I understand that the data collected here will be used for scientific 
research and will receive only impersonal statistical treatment with my 
right of privacy protected. None of my data will be revealed in individ-
ualized form to another person without my prior written consent. Fur-
ther, I recognize that I can discontinue participation in this research 
study at any time without penalty of any kind. 
I have been given adequate opportunity to ask questions, and any 
questions which have occurred to me concerning this project or this 
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informed consent have been answered to my satisfaction. 
In recognintion and understanding of the above-described project, I 
hereby freely consent to participate as a research subject. 
Witness 
DATE 
-M~O------~D~AY=------=yE=A~R~-
Signature of Research Subject 
MO DAY YEAR 
APPENDIX B 
TREADMILL PROTOCOLS 
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BRUCE TREADMILL PROTOCOL 
Time Speed - Incline 
0 - 3 minutes 1. 7 miles per hour 10% 
3 - 6 minutes 2.5 miles per hour 12% 
6 - 9 minutes 3.4 miles per hour 14% 
9 - 12 minutes 4. 2 miles per hour 16% 
12 - 15 minutes 5. 0 miles per hour 18% 
15 - 18 minutes 5. 5 miles per hour 20% 
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BALKE TREADMILL PROTOCOL . 
Time Speed Incline 
0 - 2 minute 3.3 miles per hour 0% 
2 - 3 minute 3.3 miles per hour 2% 
3 - 4 minute 3.3 miles ·per hour 3% 
4 - 5 minute 3.3 miles per hour 4% 
5 - 6 minute 3.3 miles per hour 5% 
6 - 7 minute 3.3 miles per hour 6% 
7 - 8 minute 3.3 miles per hour 7% 
8 - 9 minute 3.3 miles per hour 8% 
9 - 10 minute 3.3 miles per hour 9% 
10 - 11 minute 3.3 miles per hour 10% 
11 - 12 minute 3.3 miles per hour 11% 
12 - 13 minute 3.3 miles per hour 12% 
13 - 14 minute 3.3 miles per hour 13% 
14 - 15 minute 3.3 miles per hour 14% 
15 - 16 minute 3.3 miles per hour 15% 
16 - 17 minute 3.3 miles per hour 16% 
17- 18 minute 3.3 miles per hour 17% 
18 - 19 minute 3.3 miles per hour 18% 
19 - 20 minute 3.3 miles per hour 19% 
20 - 21 minute 3. 3 miles per hour 20% 
21 - 22 minute 3.3 miles per hour 21% 
22 - 23 minute 3. 3 miles per hour 22% 
23 - 24 minute 3.3 miles per hour 23% 
24 - 25 minute 3.3 miles per hour 24% 
APPENDIX C 
PRETREATMENT (Tl) AND POSTTREATMENT (T2) 
DATA FOR THE EXPERIMENTAL GROUP AND THE 
CONTROL GROUP SUBJECTS 
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* 
AGE (YEARS) AND HEIGHT (INCHES) FOR THE 
EXPERIMENTAL GROUP AND CONTROL GROUP 
Experimental Control 
Subject Age Height . Age Height 
1 41 70 39 70.5 
2 41 69 41 65 
3 37 72 41* 70* 
4 36 69 44 63 
5 34 72 37 71 
6 33 70 44 71 
7 40 72 45 75 
8 44 72.5 38 70 
9 37* 76* 37 69 
10 32 70 43 69 
11 43 69 30* 70* 
12 44 72 34 70 
13 36 71 39 64.75 
14 35 69 39 70 
15 32 70 43 73 
16 30 71 49 68 
17 40 71 30 70.5 
18 40 67.5 39 77 
19 45 72 42 66 
20 46 74 35 69 
21 36 72 34 72 
22 50 74 42 69.5 
23 36 69 35 72 
24 50 70 44 77 
25 37 71 46 72 
26 50 67.5 42 70.5 
27 47 71.75 45 69 
28 33 67.5 40 72 
29 40 72 42 69 
30 45 70 33 71.5 
31 43 68 43* 72* 
32 49 71 48 70 
33 49 67.5 45 66 
34 43 69.5 45 74 
35 43 68.5 39 71 
36 31* 73* 47 69.5 
Withdrew From Study 
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BODY COMPOSITION DATA FOR THE EXPERIMENTAL GROUP 
AND THE CONTROL GROUP: WEIGHT (POUNDS) 
Experimental Control 
Subject Tl T2 T1 T2 
1 188 177 185 184 
2 179.75 173 173.25 171.25 
3 202 199.75 187 
4 171.5 165.5 161 161.25 
5 213 200 168.75 168.5 
6 190.25 184.75 211.5 213.5 
7 225.5 212.5 170.75 168.5 
8 228 227.25 165 163.25 
9 253.25 184.25 181.25 
10 169.25 160.25 207.55 203.75 
11 132.5 131 192.25 
12 177.5 172 178 183.75 
13 154 154/75 169 170 
14 156 154 244.25 241.5 
15 179.5 180 239 221 
16 157.5 155 148 144.25 
17 154.25 153 156.75 161.75 
18 271.5 266 204.75 206 
19 208.5 199.5 144 144.5 
20 193.5 189.25 168.75 162 
21 198 198 192 192 
22 179.5 175 208 208.5 
23 166 1163.5 193.75 196 
24 207.5 210.75 199.75 195 
25 247.75 247.25 192.25 189.5 
26 173 169.75 173 178 
27 220 219.5 176.5 168.5 
28 168 165.5 175.25 177.5 
29 251 252 183.5 184.75 
30 200.25 195.5 180.5 182.25 
31 186.5 180 191 
32 213.5 203.5 192 169.5 
33 165 149.5 157 156 
34 169.5 171 231.75 233.25 
35 165.5 164 179.75 178 
36 201 207.5 200.5 
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BODY COMPOSITION DATA FOR THE EXPERIMENTAL GROUP: PERCENT 
BODY FAT BY SKINFOLDS .AND HYDROSTATIC WEIGHING 
Skinfolds Hydrostatic Weighing 
Subject T1 T2 T1 T2 
1 23 20.5 21.7 20.7 
2 23.2 21.2 
3 23.2 21 20.4 20.6 
4 23.4 24.1 
5 24.1 20 23.4 22.6 
6 16 14.2 
7 23.8 18.8 27.1 24.8 
8 27.1 27;.9 28 28.6 
9 
10 23.9 21. 1 
11 15.4 17.4 
12 20.3 16.8 23.5 22 
13 16.2 14 17.3 17 
14 16.2 10 
15 23.8 21.2 18.6 18.9 
16 23.8 22.5 22.7 16.1 
17 18.2 17.1 20.9 18.1 
18 34.2 32.8 
19 24.3 24.3 
20 22.8 19.8 21.2 18.8 
21 28 26.8 
22 22.3 20.5 23.4 24.1 
23 18.2 13.6 11.2 8.7 
24 22 20.3 25.9 26.4 
25 24.5 25 29.8 30 
26 25 24 23.1 23.5 
27 23.2 21 24.2 25.5 
28 21.8 18.2 18 18.8 
29 
30 20 19.6 
31 26.5 27.1 27.5 26.9 
32 23.4 19.8 27.5 21 
33 19.1 13.2 20.7 14.4 
34 14.8 15.8 7.4 7.9 
35 22.5 23.3 
36 
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BODY COHPOSITION DATA FOR THE CONTROL GROUP: PERCENT 
BODY FAT BY SKINFOLDS AND HYDROSTATIC WEIGHING 
Skinfolds Hydrostatic Weighing 
Subject Tl T2 T1 T2 
1 15. 1 16.8 21.7 20.3 
2 23.4 21.2 18.8 18 
3 
4 26.8 25 24.3 24.8 
5 24.3 23.4 21.5 22.8 
6 26.8 25.9 27.1 27.2 
7 14.8 p.4 14.6 17.7 
8 22 20 
9 21.4 18.8 23.2 23 
10 20.3 19.3 20.6 21.6 
11 
__ , 
12 26.2 27.8 26.9 24.5 
13 21.2 21.2 22.1 22.1 
14 27.5 27.3 26.9 26.2 
15 32.8 29.4 
16 
17 21. 1 22 19.1 21. 
18 26.4 25.9 
19 20 18.2 16.6 15.3 
20 21.8 18.5 16.3 17.4 
21 15.7 16.2 
22 25.5 25.2 24.6 26 
23 19.3 20.5 
24 20.5 20.3 19.3 17.7 
25 20 20 
26 22 21.2 22.3 22.9 
27 23.9 22.4 
28 14.9 16.7 
29 21.4 21. 2 24.6 25.6 
30 17.7 15.8 20.3 20.8 
31 
32 21.4 19.1 
33 25 23.6 
34 23 21.6 20.9 21.9 
35 24.3 22.5 21.1 22.6 
36 23.4 21.2 27.7 27.1 
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BLOOD LIPID DATA FOR THE EXPERIMENTAL GROUP: 
TOTAL CHOLESTEROL AND TRIGYCERIDES (mg/dl) 
Total Cholesterol Triglycerides 
Subject T1 T2 T1 T2 
1 177 194 102 86 
2 214 193 71 173 
3 179 161 97 58 
4 211 184 196 71 
5 187 150 111 58 
6 206 193 71 58 
7 261 285 161 267 
8 195 198 92 78 
9 175 82 
10 173 144 81 73 
11 200 215 85 45 
12 183 176 161 177 
13 146 135 45 37 
14 186 163 59 130 
15 221 205 102 80 
16 250 239 112 85 
17 180 151 90 88 
18 174 172 130 130 
19 219 207 110 86 
20 221 183 121 103 
21 192 195 106 157 
22 201 192 88 72 
23 202 182 90 91 
24 230 190 286 216 
25 150 146 58 74 
26 220 201 136 120 
27 165 169 113 131 
28 210 189 73 66 
29 185 174 55 54 
30 264 205 220 141 
31 240 222 112 110 
32 244 214 70 73 
33 262 181 97 51 
34 221 243 103 181 
35 199 213 178 169 
36 162 55 
BLOOD LIPID DATA FOR THE EXPERIMENTAL GROUP: PERCENT 
HDL-C (mg/dl) AND HDL-C /TC X100 (%) 
HDL-C (mg/dl) HDL-C (%) 
Subject Tl T2 T1 T2 
1 43 43 24 22 
2 67 47 31 24 
3 33 . 18 
4 45 44 21 24 
5 34 32 18 21 
6 57 55 28 28 
7 39 J8 15 13 
8 37 39 19 20 
9 43 25 
10 43 40 25 28 
11 75 66 37 31 
12 38 41 21 23 
13 55 49 38 36 
14 44 40 24 25 
15 39 37 18 18 
16 49 47 20 20 
17 57 53 32 35 
18 43 41 25 24 
19 41 41 19 20 
20 33 37 15 20 
21 40 41 21 21 
22 52 48 26 24 
23 51 46 25 25 
24 24 27 10 14 
25 41 36 27 25 
26 46 35 21 17 
27 43 35 26 21 
28 57 51 27 27 
29 47 50 25 29 
30 47 40 18 20 
31 40 35 17 16 
32 40 41 16 19 
33 59 61 23 34 
34 62 55 28 23 
35 35 35 18 16 
36 36 22 
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BLOOD LIPID DATA FOR THE CONTROL GROUP: TOTAL 
CHOLESTEROL AND TRIGLYCERIDES (mg/dl) 
Total Cholesterol Triglycerides 
Subject T1 T2 T1 T2 
1 155 171 112 81 
2 295 248 61 109 
3 226 92 
4 176 167 106 87 
5 243 227 .231 357 
6 205 206 115 120 
7 233 212 108 72 
8 159 169 108 85 
9 178 170 152 99 
10 198 164 170 228 
11 122 76 
12 232 254 227 151 
13 243 220 229 365 
14 219 215 73 90 
15 153 152 123 60 
16 242 224 168 189 
17 133 120 60 65 
18 154 149 46 53 
19 223 220 118 107 
20 183 167 65 72 
21 195 175 293 237 
22 170 170 60 56 
23 222 208 162 171 
24 169 183 80 89 
25 209 196 93 75 
26 185 195 78 56 
27 234 203 213 64 
28 205 195 82 116 
29 211 188 58 98 
30 213 207 88 104 
31 170 77 
32 205 191 45 87 
33 342 284 340 234 
34 227 225 140 315 
35 223 205 95 105 
36 203 204 97 114 
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BLOOD LIPID DATA FOR THE CONTROL GROUP: 
HDL-C (mg/dl) AND HDL-C /TC X100(%) 
HDL-C (mg/dl) HDL-C(%) 
Subject T1 T2 T1 T2 
1 40 46 26 27 
2 56 51 27 21 
3 45 20 
4 44 38 25 23 
5 35 33 14 15 
6 39 33 19 16 
7 51 45 22 21 
8 51 47 32 28 
9 36 35 20 21 
10 36 31 18 19 
11 35 29 
12 36 40 16 16 
13 26 32 11 15 
14 46 45 21 21 
15 47 46 31 30 
16 43 39 18 17 
17 46 37 35 31 
18 75 44 49 30 
19 48 52 22 24 
20 55 47 30 28 
21 36 34 18 19 
22 79 69 46 41 
23 52 47 23 23 
24 43 41 25 22 
25 39 38 19 19 
26 46 50 25 26 
27 37 37 16 18 
28 45 40 22 21 
29 50 52 24 28 
30 46 44 22 21 
31 41 24 
32 70 64 34 34 
33 33 27 10 10 
34 44 37 19 16 
35 40 40 18 19 
36 38 40 19 20 
CARDIORESPIRATORY FITNESS FOR THE EXPERIMENTAL GROUP: 
~02 AT A HEART RATE OF 150 (mlo2/kg•min-1 
and 102/min) 
(mlo2/kg•min-1) (LOz/min) 
Subject T1 T2 T1 T2 
1 23.6 2.01 
2 22.2 23.8 1.81 1. 87 
3 23.4 28.1 2.15 2.55 
4 29.6 31.2 2.3 2.35 
5 25.1 35.5 2.43 3.22 
6 29 35.9 2.5 3.01 
7 18.5 27.1 1.89 2.61 
8 25.6 28.1 2.65 2.90 
9 23.3 2.67 
10 29.6 36.9 2.28 2.68 
11 26.2 27.7 1.57 1.65 
12 21.3 29.2 1.72 2.28 
13 23.3 28.4 1.62 1.99 
14 20.7 34.1 1. 46 2.38 
15 25.1 28.4 2.04 2.32 
16 24.1 28.2 1.73 1.97 
17 20.5 23.1 1.43 1.60 
18 20.7 25.7 2.55 3.10 
19 24.2 29.9 2.28 2.71 
20 24.8 28.5 2.17 2.45 
21 27.3 30.6 2.46 2.74 
22 22.1 27.6 1.80 2.19 
23 34 38.9 2.56 2.89 
24 20.1 23.2 1.89 2.22 
25 23.3 26 2.62 2.91 
26 22 26.9 1. 72 2.07 
27 24 22.7 2.40 2.26 
28 27.2 30.2 2.07 2.27 
29 20.5 27.8 2.52 2.38 
30 27.8 26.8 2.52 2.38 
31 19.6 26.2 1.66 2.14 
32 21.8 27.8 2.11 2.57 
33 27.2 37 2.04 2.51 
34 32.1 29.4 2.47 2.28 
35 27.6 31.5 2.06 2.34 
36 19.3 1.75 
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CARDIORESPIRATORY FITNESS FOR THE EXPERIMENTAL GROUP: 
VOz AT 80% OF HEART RATE RANGE (mloz/kg•min-1 
and 102/min) 
(mlo2/kg•min-1) (L02/min) 
Subject T1 T2 T1 T2 
1 25.9 2.21 
2 26.4 28.1 2.15 2.21 
3 26.4 32.5 2.42 2.95 
4 31.3 33.9 2.44 2.54 
5 27.2 39.5 2.63 3.58 
6 33.2 38.8 2.87 3.25 
7 22.5 32.8 2.30 3.16 
8 26.8 32.8 2. 77 3.38 
9 26.9 3.08 
10 31.1 37.2 2.39 2.70 
11 25.4 30.2 1.52 1.79 
12 21.6 29.5 1.74 2.30 
13 26 33.9 1.81 2.38 
14 20.9 33.0 . 1.48 2.29 
15 27.8 33.4 2.27 2.72 
16 29.7 33.7 2.12 2.37 
17 24 27 1. 67 1.87 
18 20.3 24.6 2.50 2.97 
19 27 31.2 2.55 2.82 
20 26.2 31.5 2.29 2. 71 
21 29.5 32.8 2.66 2.95 
22 24.1 32 1.96 2.54 
23 34.3 39.1 2.58 2.91 
24 22.5 24 2.12 2.29 
25 25.7 28 2.89 3.13 
26 22.8 27.9 1.79 2.15 
27 25.7 23.6 2.57 2.35 
28 32.4 36.3 2.47 2.73 
29 23.3 32.3 2.65 3.68 
30 24.1 23 2.19 2.04 
31 21 26.6 1. 77 2.17 
32 25.3 30.8 2.45 2.84 
33 31.1 42.1 2.34 2.86 
34 34.7 33.9 2.67 2.63 
35 29.2 33.8 2.19 2.48 
36 25.9 2.37 
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CARDIORESPIRATORY FITNESS FOR THE EXPERIMENTAL GROUP: 
ESTIMATED V02 MAXIMUM (mlo2/kg•min-1 ·and L02/min). 
(mlo2/kg •min-1) (L02/min) 
Subject T1 T2 T1 T2 
1 32.3 2.75 
2 30.5 32.2 2.49 2.53 
3 31.2 40.4 2.86 3.66 
4 37.4 41.8 2.91 3.14 
5 35.2 49.2 3.40 4.46 
6 39.8 48.5 .3. 43 4.06 
7 27.7 39.9 2.83 3.85 
8 -31.8 38.8 3.29 4.00 
9 32.7 3.75 
10 35.6 45.7 2.73 3.32 
11 32.6 33.9 1.96 2.01 
12 26.1 35.3 2.10 2.75 
13 33 40.5 2.30 2.84 
14 29.8 43.1 2.11 3.01 
15 33.9 37.3 2.76 3.04 
16 35.1 39.5 2.51 2.78 
17 28.8 31.6 2.01 2.19 
18 23.3 30.4 2.87 3.67 
19 29.9 37.8 2.83 3.42 
20 31.2 37.8 2.83 3.42 
21 34.3 39.1 3.08 3.51 
22 29.4 38.1 2.39 3.02 
23 40.2 47.7 3.03 3.54 
24 26.8 28.8 2.52 2.75 
25 29.8 34.3 3.35 3.85 
26 27.7 32.5 2.17 2.50 
27 30.8 28.5 3.07 2.84 
28 39.7 44.1 3.03 3.31 
29 28.1 39 3.20 4.46 
30 28.6 28.2 2.60 2.50 
31 24.6 34.7 2.08 2.83 
32 29.5 38.7 2.86 3.57 
33 37 50.9 2. 77 3.45 
34 43.5 41.7 3.32 3.23 
35 34.7 40.7 2.60 3.03 
36 30.2 2.75 
74 . 
• CARDIORESPIRATORY FITNESS FOR THE CONTROL GROUP: V02 
AT A HEART RATE OF 150 ((mlo2/kg•min-1 and L02/min) 
(mlo2/kg•min-1) (L02/min) 
Subject T1 T2 T1 T2 
1 28.1 27.8 2.36 2.32 
2 30.9 35.8 2.43 2.79 
3 25.6 2.17 
4 25.0 22.2 1.82 1.62 
5 21.4 24.4 1.64 1. 86 
6 25.3 25.3 2.43 2.45 
7 26.7 26.0 2.07 2.00 
8 20.4 22.3 1.53 1.65 
9 22.4 24.5 1.87 2.01 
10 27.9 24.7 2.63 2.28 
11 26.2 2.29 
12 23.4 21.8 1.88 1.82 
13 21.0 22.3 1.61 1. 72 
14 29.3 31.5 3.25 3.45 
15 19.5 24.5 2.11 2.43 
16 21.4 23.7 1.44 1.55 
17 23.6 22.9 1.62 1.67 
18 23.9 23.2 2.22 2.17 
19 21.5 21.5 1.40 1.41 
20 29.6 28.7 2.26 2.10 
21 23.9 30.6 2.09 2.67 
22 29.5 31.5 2.78 2.98 
23 26.4 27.0 2.32 2.44 
24 26.0 27.5 2.36 2.44 
25 18.6 23.6 1.62 2.02 
26 24.8 25.1 1.94 2.03 
27 22.2 29.2 1. 77 2.23 
28 27.8 28.0 2.21 2.26 
29 27.2 28.9 2.27 2.42 
30 23.8 27.7 1.95 2.29 
31 19.4 1.68 
32 21.2 24.2 1.84 1.93 
33 20.9 22.1 1.49 1.56 
34 20.4 19.6 2.14 2.07 
35 23.2 17.4 1.89 1.41 
36 24.6 26.0 2.32 2.36 
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. CARDIORESPIRATORY FITNESS FOR THE CONTROL GROUP: VOz 
AT 80% OF HEART RATE RANGE ((mlo2/kg•min-1 
and 102/min) 
(mlo2/kg•min-l) (Lo2/min) 
Subject Tl T2 T1 T2 
1 29.5 31.6 2.47 2.64 
2 32.2 37.7 \ 2. 53 2.92 
3 29,0 2.46 
4 25.1 22.6 1.83 1.65 
5 24.6 25.2 1.88 1.93 
6 28.0 30.6 2.69 2.96 
7 30.6 28.8 2.37 2.21 
8 23.6 25.2 1.76 1.86 
9 24.7 27.8 2.07 2.28 
10 26.0 28.6 2.44 2.64 
11 28.0 2.44 
12 25.6 22.4 2.07 1.87 
13 21.2 22.4 2.07 1.87 
14 30.2 32.0 3.35 3.50 
15 22.3 28.1 2.41 2.81 
16 24.5 25.9 1.64 1.70 
17 28.7 29.5 2.04 2.16 
18 27.1 25.2 2.51 2.35 
19 26.0 28.4 1.69 1.86 
20 31.6 35.9 2.41 2.63 
21 27.1 32.4 2.36 2.82 
22 31.0 32.8 2.93 3.10 
23 30.0 29.0 2.64 2.58 
24 27.2 29.8 2.47 2.63 
25 21.0 26.4 1.83 2.22 
26 27.2 26.4 2.14 2.13 
27 26.4 32.2 2.12 2.46 
28 30.8 31.4 2.45 2.52 
29 29.0 31.2 2.41 2.61 
30 27.7 33.8 2.27 2.79 
31 25~4 2.20 
32 22.2 28.2 1.94 2.17 
33 24.4 24.7 1.73 1.75 
34 23.6 24.7 2.48 2.61 
35 26.5 24.4 2.16 1.97 
36 23.4 25.0 2.20 2.27 
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CARDIORESPIRATORY FITNESS FOR THE CONTROL GROUP: 
ESTIMATED V02 MAXIMUM (mlo2/kg•min-1 and L02/min) 
(mlo2/kg•min-1) (L02/min) 
Subject T1 T2 Tl T2 
1 36.9 37.0 3.10 3.09 
2 40.9 46.9 3.21 3.64 
3 34.9 2.96 
4 30.3 28.8 2.21 2.11 
5 27.0 29.5 2.07 2.25 
6 33.1 35.8 3.17 3.47 
7 36.1 35.2 2.80 2.69 
8 27.1 30.0 2.03 2.22 
9 30.2 35.2 2.52 2.89 
10 26.9 32.0 2.53 2.96 
11 34.6 3.02 
12 29.1 32.0 2.53 2.96 
13 24.5 26.8 1.88 2.07 
14 35.3 37.9 3.91 4.15 
15 26.1 32.3 2.83 3.24 
16 27.5 29.0 1.85 1.90 
17 34.4 34.7 2.45 2.55 
18 32.3 30.3 3.00 2.83 
19 29.7 32.3 1.94 2.12 
20 38.4 43.7 2.94 3.21 
21 33.2 38.9 2.89 3.39 
22 38.3 39.6 3.61 3.74 
23 35.1 36.0 3.08 3.20 
24 35.5 35.5 3.21 3.14 
25 26.4 30.0 2.30 2.58 
26 31.5 31.0 2.47 2.50 
27 31.0 39.5 2.48 3.02 
28 36.4 38.6 2.89 3.11 
29 33.7 36.3 2.80 3.21 
30 32.7 38.8 2.68 3.21 
31 29.9 2.59 
32 24.6 34.6 2.14 2.66 
33 28.7 28.9 2.04 2.04 
34 28.2 29.0 2.96 3.07 
35 31.5 29.3 2.57 2.37 
36 26.8 29.0 2.52 2.64 
SMOKING AND ALCOHOL CONSUMPTION DATA FOR THE EXPERIMENTAL 
GROUP AND CONTROL GROUP (SMOKER - * DRINKER (ALCOHOL - +) 
· ExJZerimental · Control 
Subject Smokers Drinkers -Smokers Drinkers 
1 
* + + 2 + 
3 
4 
5 + 
6 + + 
7 
8 
* + 9 + 
10 + 
11 
* + 12 
* + 13 + + 
14 
15 + + 
16 
* + 17 + 
18 + 
19 + 
20 + + 
21 + 
22 + + 
23 + * + 24 + + 
25 + * + 26 + + 
27 + 
28 + * + 29 + + 
30 
* + + 31 
32 + 
33 + 
34 + 
35 + 
36 
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